Literature DB >> 477250

A comparison of chromium sesquioxide and [51Cr]chromic chloride as inert markers in calcium balance studies.

R Hesp, D Williams, M Rinsler, J Reeve.   

Abstract

1. Chromium sesquioxide (Cr2O3; 1.5 g/day) and [51Cr]chromic chloride [51CrCl3 (0.3 muCi/day)] were compared as continuously administered non-absorbed markers for the correction of faecal recoveries in 14 calcium balance studies each lasting at least 18 days. 2. The mean recoveries of each, 98.4% for Cr2O3 and 101.9% for 51CrCl3, were not significantly different from 100%. 3. The two markers reduced the uncertainity in a typical 3 x 6 day calcium balance study to a similar extent (SD = 1.4 mmol/day for Cr2O3 and SD = 1.5 mmol/day for 51CrCl3. 4. 51CrCl3 is a convenient and satisfactorily alternative to Cr2O3 when the laboratory hazards associated with estimating the latter cannot easily be eliminated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477250     DOI: 10.1042/cs0570089

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

1.  Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.

Authors:  M Arlot; C Edouard; P J Meunier; R M Neer; J Reeve
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-01

2.  Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.

Authors:  M Tellez; M E Arlot; E B Mawer; A Diaz; R Hesp; P Hulme; C Edouard; J R Green; P J Meunier; J Reeve
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

3.  Temporal variations in iliac trabecular bone formation in vertebral osteoporosis.

Authors:  M E Arlot; J N Bradbeer; C Edouard; J R Green; R Hesp; J P Roux; P J Meunier; J Reeve
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

4.  Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.

Authors:  D M Slovik; R M Neer; J T Potts
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.